Home > News > New Nano Protection Against HIV And Herpes
July 13th, 2006
New Nano Protection Against HIV And Herpes
Abstract:
Josh Wolfe: Long-time readers of my newsletter, Forbes/Wolfe Nanotech Report, may remember my bullish comments on a small Aussie company called Starpharma Ltd. I described the development of its lead product, VivaGel, as one of the top five nanotech breakthroughs of 2004, and added its stock to my Nanosphere portfolio in January 2005. Despite the recent drop in its share price, Starpharma's prospects are burning even brighter today.
Source:
forbes.com
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||